Story perspectives

JAX and NYSCF Join Forces to Revolutionize Biomedical Research

10/21/2025

40 6

Summary

Story summary

The Jackson Laboratory (JAX) has acquired the New York Stem Cell Foundation (NYSCF), forming a unified biomedical platform.
The collaboration combines JAX's expertise in genetics and mouse models with NYSCF's stem cell technologies.
The platform aims to accelerate early-stage research and drug discovery, advancing therapies for Alzheimer's and cancer.
It will deploy AI and automation for patient-specific modeling and predictive analytics, maintaining nonprofit status and expanding its global research network.

1 of 1

Story summary

The Jackson Laboratory (JAX) has acquired the New York Stem Cell Foundation (NYSCF), forming a unified biomedical platform.
The collaboration combines JAX's expertise in genetics and mouse models with NYSCF's stem cell technologies.
The platform aims to accelerate early-stage research and drug discovery, advancing therapies for Alzheimer's and cancer.
It will deploy AI and automation for patient-specific modeling and predictive analytics, maintaining nonprofit status and expanding its global research network.